Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

298

HTML

2886

Tables (1-3)

119

Sum=3303

Nov 15, 2003 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Nov 15, 2003; 9(11): 2622-2626
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2622

Table 3 Prognosis of SAP and FSAP

	SAP group	FSAP group
Number of cases	22	9
Rate of adsorption of pseudocyst	77.3% (17/22)	11.1% (1/9)
Time interval for absorptionof pseudocyst	135.1 ± 137.5	96
Non-operation cure rate	100% (22/22)	11.1% (1/9)
Hospital stay (days)	54.2 ± 35.9	99.1 ± 49.5
Survival rate	100% (22/22)	66.7% (6/9)

Citation: Mao EQ, Tang YQ, Zhang SD. Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis. World J Gastroenterol 2003; 9(11): 2622-2626
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2622.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i11.2622